
|Articles|October 15, 2014
Unlocking the True Value of Big Data: A Pharm Exec Global Digest Special
In this special issue of Pharm Exec Global Digest: Unlocking the true value of Big Data; Data privacy and the health sciences; In-silico modeling and real-word outcomes; and more…
Advertisement
In this special issue of Pharm Exec Global Digest: Unlocking the true value of Big Data; Data privacy
and the health sciences; In-silico modeling and real-word outcomes; and more…
This entry was posted in
Strategy
. Bookmark the
permalink
.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Evolving Relationship Between FDA and Biotech
4
What Kinds of Disruption are GLP-1s Expected to Face
5




